Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex.

The safety and pharmacokinetics of recombinant CD4-immunoglobulin G (rCD4-IgG) were evaluated in a phase 1 study with dose escalation. A total of 16 patients, 6 with AIDS and 10 with AIDS-related complex, were evaluated at two university-affiliated hospital clinics. rCD4-IgG was administered once we...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hodges, T L, Kahn, J O, Kaplan, L D, Groopman, J E, Volberding, P A, Amman, A J, Arri, C J, Bouvier, L M, Mordenti, J, Izu, A E
Format: Artigo
Langue:Inglês
Publié: 1991
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC245434/
https://ncbi.nlm.nih.gov/pubmed/1810192
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires